Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corticosteroid Pretreatment with Denileukin Difitox in CTCL
NCT00006345Phase 2Completed
- Sponsor
- Ligand Pharmaceuticals
- Start
- Nov 1999
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of dexamethasone in cutaneous T-cell lymphoma (CTCL), sponsored by Ligand Pharmaceuticals. Primary endpoint: Incidence of Hypersensitivity, Flu-like Symptoms, and Vascular Leak Syndrome. Started Nov 1999; status: completed.
02
Drugs
dexamethasone
03
Conditions
cutaneous T-cell lymphoma (CTCL)
Beyond the preview
Go deeper on NCT00006345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006345.